Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04394715 · ClinicalTrials.gov registry record · NA
Pragmatic Trial of Messaging to Providers About Treatment of Hyperlipidemia (PROMPT-LIPID)
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 2,596
- Enrollment target
NCT04394715: Completed NA study, sponsored by Yale University.
NCT04394715 is a NA study that has completed, run by Yale University. The registered enrollment target is 2,596 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04394715, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,596 participants
- Enrollment target
Study Summary
This study is designed to evaluate the efficacy of automated electronic alerts in the electronic health record to improve rates of best practices in the treatment of patients with hyperlipidemia who present in the setting of outpatient primary care and family medicine practices within the Yale New Haven Health System.
Primary Outcome
Intensification of lipid lowering therapy is defined as an increase in statin dose, an addition of ezetimibe, or addition of PCSK9. Any one of the three will be sufficient to meet this endpoint. Proportion of patients who meet this endpoint will be compared between study arms.
Interventions
- OTHER Electronic Alert
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,596 participants |
| Start Date | 2021-06-01 |
| Est. Completion | 2022-09-09 |
| Phase | NA |
What the finished NCT04394715 record still lists
NCT04394715 is an interventional study that assigns participants to a tested intervention. Its 2,596 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% higher).
The record links to 0 conditions, and to 1 intervention - of which Electronic Alert is the first listed.
NCT04394715 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04394715 about?
NCT04394715 is a clinical study titled "Pragmatic Trial of Messaging to Providers About Treatment of Hyperlipidemia (PROMPT-LIPID)". This study is designed to evaluate the efficacy of automated electronic alerts in the electronic health record to improve rates of best practices in the treatment of patients with hyperlipidemia who present in the setting of outpatient primary care and family medicine practices within the Yale New H...
What is the current status of trial NCT04394715?
This trial is currently completed. It is a NA study. The enrollment target is 2,596 participants. The study started on 2021-06-01. Estimated completion is 2022-09-09.
What interventions are being tested in trial NCT04394715?
The interventions under investigation include: Electronic Alert (OTHER).
Who is sponsoring clinical trial NCT04394715?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04394715's enrollment target sits among peer trials
2,596 44th of 2000 higher than 1,957 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06033950 · 2,600 participants · Phase 3
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
- NCT06574672 · 2,600 participants · NA
Embedded Palliative Care in the MICU
- NCT06370520 · 2,592 participants
Screening Emotions in Adolescents at the Hospital for mTBI
- NCT06018285 · 2,572 participants · NA
Stepped Approach to Reducing Risk of Suicide in Primary Care
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI